MAI Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $17.8K | Sell |
|
|||||
|
2025
Q2 | $41.2K | Buy |
|
|||||
|
2025
Q1 | $18K | Sell |
|
|||||
|
2024
Q4 | $38.2K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $625K | Hold |
|
|||||
|
2022
Q1 | $601K | Buy |
|
|||||
|
2021
Q4 | $483K | Buy |
|
|||||
|
2021
Q3 | $509K | Buy |
|
|||||
|
2021
Q2 | $500K | Sell |
|
|||||
|
2021
Q1 | $500K | Buy |
|
|||||
|
2020
Q4 | $420K | Sell |
|
|||||
|
2020
Q3 | $525K | Buy |
|